Proceedings of the 19 th Otorhinolaryngology head and neck surgery national congress (PERHATIKL 2022)

<Previous Article In Volume
Next Article In Volume>

The Role of Nimotuzumab and an Anti-Egfr Mab, in the Treatment of Locally Advanced Scchn

Authors
Nur Akbar Aroeman1, *, Andrio Raymos1
1Department of Otorhinolaryngology - Head and Neck Surgery, Faculty of Medicine, Padjadjaran University / Hasan Sadikin General Hospital, Bandung, Indonesia
*Corresponding author.
Corresponding Author
Nur Akbar Aroeman
Available Online 31 October 2023.
DOI
10.2991/978-94-6463-280-4_4How to use a DOI?
Keywords
SCCHN; Upper aerodigestive tract; Epithelial neoplasms
ABSTRACT

SCCHN is a group of neoplasms that develop in the epithelium of the upper gastrointestinal and airway, and it is a diverse disease. Approximately 65,000 individuals were estimated to be affected by SCCHN in the US in 2019, while a significant number of new cancer diagnoses in the oral cavity, pharynx, and lips were reported in South Korea, resulting in 1,170 fatalities from the disease in 2015. In recent decades, significant progress has been made in SCCHN patient treatment outcomes, with a significant increase in the percentage of patients who survived for five years in South Korea. This progress is partly attributed to improvements in surgical and radiation methods, enhanced supportive care, and changes in patient characteristics. In the past, smoking and alcohol consumption have been identified as the predominant etiological factors for SCCHN, while occasional cases have been attributed to chewing betel nut or genetic predisposition, such as in the case of Fanconi anemia.

Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the 19 th Otorhinolaryngology head and neck surgery national congress (PERHATIKL 2022)
Series
Advances in Health Sciences Research
Publication Date
31 October 2023
ISBN
10.2991/978-94-6463-280-4_4
ISSN
2468-5739
DOI
10.2991/978-94-6463-280-4_4How to use a DOI?
Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

risenwbib
TY  - CONF
AU  - Nur Akbar Aroeman
AU  - Andrio Raymos
PY  - 2023
DA  - 2023/10/31
TI  - The Role of Nimotuzumab and an Anti-Egfr Mab, in the Treatment of Locally Advanced Scchn
BT  - Proceedings of the 19 th Otorhinolaryngology head and neck surgery national congress (PERHATIKL 2022)
PB  - Atlantis Press
SP  - 17
EP  - 20
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-280-4_4
DO  - 10.2991/978-94-6463-280-4_4
ID  - Aroeman2023
ER  -